Molteno3® for physicians
The Molteno3® glaucoma drainage device achieves consistent, long-term IOP control in cases of severe and complex glaucoma, with the added benefit of a simplified surgical procedure.
Molteno3® for patients
Implanted in thousands of patients worldwide, the Molteno3® glaucoma drainage device can reduce the elevated intraocular pressure associated with glaucoma.
2RT Pivotal Study and Regulatory Pathway Presentation
ASX Announcement General AlphaRET
3 May, 2022
Nova Eye Medical Announces Regulatory Pathway for AlphaRET 2RT in the USA
ASX Announcement General AlphaRET
3 May, 2022
Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance
Media Release General iTrack
19 Apr, 2022
Latest Events
See allEuropean Glaucoma Society (EGS) 2022
Athens, Greece
4
- 8 Jun, 2022
Register for updates
Asia Pacific Association of Cataract and Refractive Surgeons (APACRS) 2022
Seoul, South Korea
10
- 12 Jun, 2022
Register for updates
Asia Pacific Glaucoma Congress (APGC) 2022
Kuala Lumpur, Malaysia
5
- 7 Aug, 2022
Register for updates
Contact us